Clinical Trial Update: Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing blood pressure reduction, safety, and tolerability of canagliflozin in adults with type 2 diabetes and hypertension on stable a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• INVOKANA (CANAGLIFLOZIN)

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Diabetes Mellitus, Type 2, Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2016-04-06